MedPath

Outpatient Foley Catheter for Induction of Labor in Nulliparous for Prolonged Pregnancy

Not Applicable
Terminated
Conditions
Induction of Labour
Prolonged Pregnancy
Registration Number
NCT02932319
Lead Sponsor
University Hospital, Lille
Brief Summary

15 to 20 % of nulliparous needs an induction at term. None study has evaluated Foley catheter induction at home versus expectative in this population

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
43
Inclusion Criteria
  • prolonged pregnancy (D+4) nulliparous no complication during pregnancy location near th hospital (20 mn by car) Bishop < 6
Exclusion Criteria
  • medical history small for gestationnal age PROM Live alone

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Bishop scoreat term birth +5 days

Measure the evolution of Bishop score,change between the randomization and the return of the patient

Secondary Outcome Measures
NameTimeMethod
Fetal complicationsthrough study completion, at 4 day
number of birthbetween the term consultation + 4 days (randomization) and delivery time
Total dose of prostaglandin used in case of cervical ripening.During labor
Labour wardat term birth +5 days
Caesarean ratebefore labor and during labor
Maternal complicationsthrough study completion, at 4 day

It's the time between the term consultation + 4 days (randomization) and delivery time (day 4)

Neonatal complicationsthrough study completion, at 4 day
delivery ratewithin 24 hours and 48 hours after randomization
Duration of hospital staythrough study completion, at 4 day
Total dose of Ocytocin used or not for induction laborDuring labor
Utilization rate of oxytocinDuring labor

Trial Locations

Locations (5)

CHU de Caen

🇫🇷

Caen, France

Hôpital Jeanne de Flandre - CHRU

🇫🇷

Lille, France

CH Roubaix

🇫🇷

Roubaix, France

CHU Rouen

🇫🇷

Rouen, France

Ch Valenciennes

🇫🇷

Valenciennes, France

CHU de Caen
🇫🇷Caen, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.